Phase 1

Oncology·MeSH: Colorectal Neoplasms

16 drugs in development·14 companies·2 clinical trials

Drug Pipeline by Phase

Phase 3(1)

Drug	Company
surzebiclimab	BeOne Medicines Ltd. (ONC)

Phase 2(1)

Drug	Company
ATI-052	Aclaris Therapeutics, Inc. (ACRS)

Phase 1(9)

Drug	Company
an8025 is a multifunctional antibody fusion protein	Adlai Nortye Ltd. (ANL)
an9025	Adlai Nortye Ltd. (ANL)
APG333	Apogee Therapeutics, Inc. (APGE)
BA3182 (CAB-EpCAM x CAB-CD3)	BioAtla, Inc. (BCAB)
EOS-984	iTeos Therapeutics, Inc. (ITOS)
HC-7366	ENANTA PHARMACEUTICALS INC (ENTA)
keyhole limpet hemocyanin	Tonix Pharmaceuticals Holding Corp. (TNXP)
tnx-1500	Tonix Pharmaceuticals Holding Corp. (TNXP)
zelebrudomide	Nurix Therapeutics, Inc. (NRIX)

Unknown(2)

Drug	Company
nlrp3 program	BioAge Labs, Inc. (BIOA)
ovarian cancer car-t therapy	Anixa Biosciences Inc (ANIX)

Phase 1/Phase 2(3)

BioSniper tracks 16 drugs in development for Phase 1 across 14 companies.

There are 2 clinical trials targeting Phase 1 tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.